Following the FDA's announcement that it will be reassessing the safety of prescription testosterone products, Abbot Laboratories Inc.
New studies have suggested a strong link between Low T medications and an increased risk of heart attacks in certain patients.
The latest news on the litigation involving Takeda Pharmaceutical's product Actos.
Jansseen Pharmaceutical Inc. is brought to court for allegedly keeping patients in the dark about the safety of its' drug, Risperdal.
Pradaxa seems to have lost some crucial folders that could have better warned those taking the medication.
Research shows that J&J's anti-psychotic drug, Risperdal, may not be what it claims to be.
Takeda Pharmaceuticals is faced with a unique lawsuit for their product, Actos.
Latest news in the Actos lawsuit.
An antidote is in the works for the reversal of the anticoagulant effect Pradaxa is dangerously known for.
Pradaxa has remained at the top of the FDA's adverse event report list during its entire lifespan on the market.